S.E. Brett, P. Forte, P.J. Chowienczyk, N. Benjamin and J.M. Ritter ...

Nebivolol (Bystolic®), a novel, highly cardioselective, third-generation β-blocker that recently received approval by the US FDA for the treatment of hypertension in the USA, is effective in ...